Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Pharmacokinetics of two methylprednisolone prodrugs compared in asthmatics

June 25, 1997

No Comments

Pulmicort Turbuhaler approved by FDA

June 25, 1997

No Comments

Antiasthmatic activity of NPC-17731 in primate model

June 24, 1997

No Comments

Recombinant PAF-AH progresses to phase II for ARDS

June 24, 1997

No Comments

New orally active oligopeptide antiallergic from Central Drug Res. Inst.

June 23, 1997

No Comments

Orally active MDP derivative as lead for antiallergic compounds

June 23, 1997

No Comments

Labopharm and Sepracor to develop new dosage forms of levalbuterol

June 20, 1997

No Comments

PPL Therapeutics authorized to start phase II trials with transgenic product

June 18, 1997

No Comments

Dainippon Ink presents new antiallergic/antiasthmatic agent

June 18, 1997

No Comments

New asthma treatment now available in Canada

June 17, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Respiratory
RSS

Pharmacokinetics of two methylprednisolone prodrugs compared in asthmatics

Pulmicort Turbuhaler approved by FDA

Antiasthmatic activity of NPC-17731 in primate model

Recombinant PAF-AH progresses to phase II for ARDS

New orally active oligopeptide antiallergic from Central Drug Res. Inst.

Orally active MDP derivative as lead for antiallergic compounds

Labopharm and Sepracor to develop new dosage forms of levalbuterol

PPL Therapeutics authorized to start phase II trials with transgenic product

Dainippon Ink presents new antiallergic/antiasthmatic agent

New asthma treatment now available in Canada

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Cell mapping yields clues to metabolic health in obese individuals

Ionis notches Arrowhead win; Tryngolza cleared for FCS

Respiratory RSS

Respiratory
RSS